-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

322.O3.6 322. Disorders of Coagulation or Fibrinolysis: Hemophilia: Genes, Joints, and PK

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Hemophilia, Adult, Bleeding Disorders, Diseases, Non-Biological, Bleeding and Clotting, Therapies, Elderly, Genetic Disorders, Pediatric, Biological Processes, coagulant drugs, Technology and Procedures, Young Adult, Study Population, genomics, Clinically relevant, pharmacology, inflammation, iron metabolism, iron transport, RNA sequencing, pathogenesis, WGS
Saturday, December 5, 2020: 2:00 PM-3:30 PM
Moderators:
Amanda B Payne, PhD, MPH, Centers for Disease Control and Prevention and Cristina Tarango, MD, Cincinnati Children's Hospital Medical Center
Disclosures:
Tarango: Sanofi: Honoraria, Other; Bayer: Consultancy, Other.
2:00 PM

Jill M Johnsen, MD1,2, Shelley N Fletcher1*, Angela Dove1*, Haley McCracken1*, Beth K Martin3*, Martin Kircher3*, Neil C Josephson, MD1,2, Jay Shendure3*, Sarah Ruuska, MPH1*, Leonard A. Valentino, MD4, Glenn Pierce, MD, PhD4, Crystal Watson, BS5*, Dunlei Cheng, PhD5*, Michael Recht, MD, PhD5 and Barbara A. Konkle, MD1,2

1Bloodworks Research Institute, Seattle, WA
2Department of Medicine, University of Washington, Seattle, WA
3Genome Sciences, University of Washington, Seattle, WA
4National Hemophilia Foundation, New York, NY
5American Thrombosis and Hemostasis Network, Rochester, NY

2:15 PM

Marsha M Wheeler, Phd1*, Kathryn Sheldon2*, Shelley N Fletcher2*, Angela Dove2*, Kerry W Lannert2*, Chris Frazar3*, Barbara A. Konkle, MD2,4, Deborah A Nickerson3* and Jill M Johnsen, MD2,4

1Department of Genome Sciences, University of Washington, Washington, MD
2Bloodworks Research Institute, Seattle, WA
3Department of Genome Sciences, University of Washington, Seattle, WA
4Department of Medicine, University of Washington, Seattle, WA

2:30 PM

Esther J Cooke, PhD1*, Chanond A Nasamran2*, Kathleen Fisch, PhD2* and Annette von Drygalski, MD, Pharm D3

1Department of Medicine, Division of Hematology/Oncology, University of California San Diego, La Jolla, CA
2Center for Computational Biology and Bioinformatics, University of California San Diego, La Jolla, CA
3Department of Medicine, Division of Hematology/Oncology, University of California San Diego, San Diego, CA

2:45 PM

Akram Mesleh Shayeb, MD1, Richard Barnes, PhD, MPH1*, Nicolas Gallastegui Crestani, MD1, Cris Hanacek, BS1*, Peter Aguero, PT, DPT1*, Andres Flores, MS, ATC, CES1*, Rebecca Kruse-Jarres, MD2, Bruno Steiner, PT, DPT, LMT, RMSK2*, Doris Quon, MD, PhD3, Cindy Bailey, DPT, OCS, SCS, ATC3* and Annette von Drygalski, MD, Pharm D1

1Department of Medicine, Division of Hematology/Oncology, University of California San Diego, San Diego, CA
2Washington Center for Bleeding Disorders at Bloodworks Northwest, University of Washington, Seattle, WA
3Los Angeles Orthopedic Hemophilia Treatment Center, Orthopedic Institute for Children, Los Angeles, CA

3:00 PM

Olav Versloot, MSc.1*, Emma Iserman2*, Pierre Chelle, PhD3*, Federico Germini, MD, MSc2,4*, Tushara Mathew2*, Alfonso Iorio, MD, PhD5,6 and Kathelijn Fischer7*

1van Creveldkliniek, UMC Utrecht, Utrecht, Netherlands
2Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada
3School of Pharmacy, University of Waterloo, Waterloo, ON, Canada
4Department of Medicine, McMaster University, Hamilton, ON, Canada
5Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada
6McMaster-Bayer Endowed Research Chair in Clinical Epidemiology of Congenital bleeding Disorders, Department of Medicine, McMaster University, Hamilton, Canada
7Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands

3:15 PM

Olav Versloot, MSc.1*, Emma Iserman2*, Pierre Chelle, PhD3*, Federico Germini, MD, MSc2,4*, Tushara Mathew2*, Alfonso Iorio, MD, PhD5,6 and Kathelijn Fischer7*

1van Creveldkliniek, UMC Utrecht, Utrecht, Netherlands
2Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada
3School of Pharmacy, University of Waterloo, Waterloo, ON, Canada
4Department of Medicine, McMaster University, Hamilton, ON, Canada
5Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada
6McMaster-Bayer Endowed Research Chair in Clinical Epidemiology of Congenital bleeding Disorders, Department of Medicine, McMaster University, Hamilton, Canada
7Van Creveldkliniek, University Medical Center, Utrecht, NLD

*signifies non-member of ASH